Most therapeutic approaches in immuno-oncology focus on targeting the adaptive immune system; innate immunity has only recently gathered momentum. Here, Arndt Schottelius of Affimed, shares insights on unleashing the potential of the innate immune system.
Germany
German
Arndt-schottelius